Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit

Neutropenia, defined by an absolute count of polymorphonuclear neutrophils less than <1500/mm3, exposes patients to infectious complications that can lead to sepsis or septic shock. The mortality risk is higher risk. The recommendations published in 2016 were formulated to homogenize the clinical practices to improve the survival.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neutropenia, Febrile Agranulocytosis Cytopenia Febrile Neutropenia Hematologic Diseases Hemic and Lymphatic Diseases Leukocyte Disorders Leukopenia Neutropenia

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest

Brest, 29609, France

About this study

We evaluate the adequacy antibiotics prescriptions in febrile neutropenia with suspected infection and evaluate factors influencing adequacy therapy and mortality consequence.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Sepsis or septic shock at admission or during the stay

Exclusion criteria

Minor
Pregnancy
Opposition

Treatment and study plan

Primary outcomes

Proportion of adequate antibiotic prescription

Time frame: Through study completion, an average of 1 month

Proportion of adequate antibiotic prescription

Secondary outcomes

Mortality of all causes

Time frame: ICU, hospital and 28-day mortality

Mortality of all causes

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit : New Recommendations do They Change Our Clinical Practice ?

Acronym: REANEUF

Important dates

Study start: 2017
Primary completion: 2017
Study completion: 2017
First posted: Jul 14, 2017
Registry last updated: Aug 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed